1. Home
  2. Adalimumab
  Subject:

Adalimumab   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects
Rheumatoid arthritis  9 times
Etanercept  9 times
Infliximab  8 times
Methotrexate  7 times
Psoriasis  5 times
Necrosis  5 times
Inflammatory bowel disease  5 times
Tumor necrosis factor alpha  4 times
Tocilizumab  4 times
Monoclonal antibody  4 times
Enzyme inhibitor  4 times
Antibody  4 times
Placebo  3 times
Pharmacokinetics  3 times
Odds ratio  3 times
Disease-modifying antirheumatic drug  3 times
Ankylosing spondylitis  3 times
Uveitis  2 times
Ulcerative colitis  2 times
Tumor necrosis factor superfamily  2 times
Rituximab  2 times
Markov chain  2 times
Juvenile idiopathic arthritis  2 times
Joint effusion  2 times
Gene  2 times
European Medicines Agency  2 times
DNA  2 times
Credible interval  2 times
Corticosteroid  2 times
Colorectal cancer  2 times
ClinicalTrials.gov  2 times
Clinical trial  2 times
Ciclosporin  2 times
C-reactive protein  2 times
Biosimilar  2 times
Abatacept  2 times
Vaccine  1 time
Transfection  1 time
Therapeutic drug monitoring  1 time
Systemic lupus erythematosus  1 time
Syndrome  1 time
Stenosis  1 time
Spondylitis  1 time
Skin cancer  1 time
Single-nucleotide polymorphism  1 time
Sensitivity analysis  1 time
Sarcoidosis  1 time
Puerto Rico  1 time
Psoriatic arthritis  1 time
Protein  1 time
Proportional hazards model  1 time
Prednisone  1 time
Prednisolone  1 time
Polymerase chain reaction  1 time
Polyethylenimine  1 time
Plasmid  1 time
Optical coherence tomography  1 time
National Health Service  1 time
Mutation  1 time
Metabolism  1 time
Memory  1 time
Medical ultrasound  1 time
Magnetic resonance imaging  1 time
Macular edema  1 time
Logistic regression  1 time
Light therapy  1 time
Large intestine  1 time
Kaplan–Meier estimator  1 time
Joint stiffness  1 time
Japan  1 time
Israel  1 time
Ischemia  1 time
International law  1 time
International  1 time
Interferon  1 time
Innate immune system  1 time
Immunotherapy  1 time
Hungary  1 time
Hepatitis B  1 time
Hair loss  1 time
HBsAg  1 time
Grayscale  1 time
Gastrointestinal bleeding  1 time
France  1 time
Fish measurement  1 time
Dysplasia  1 time
Diarrhea  1 time
Dermatitis  1 time
Decision tree  1 time
Cutaneous condition  1 time
Covariate  1 time
County Mayo  1 time
Confidence interval  1 time
Colectomy  1 time
California  1 time
Calcineurin  1 time
Biotechnology  1 time
Biomimetics  1 time
Bioavailability  1 time
Bcl-xL  1 time
Bath Rugby  1 time
Azathioprine  1 time
Australia  1 time
Aureus  1 time
Arthritis  1 time
Apoptosis  1 time
Anterior chamber of eyeball  1 time
Angiography  1 time
Ancient Greece  1 time
Algorithm  1 time

Publications tagged with this subject: 29

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. Mucosal Healing in Ulcerative Colitis: A Comprehensive Review

2. Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation

3. Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

4. Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study

5. Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents

6. Comparative efficacy and safety of baricitinib 2 mg and 4 mg in patients with active rheumatoid arthritis

7. Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry

8. Fluorescence optical imaging and musculoskeletal ultrasonography in juvenile idiopathic polyarticular disease before and during antirheumatic treatment - a multicenter non-interventional diagnostic evaluation

9. A BioDesign Approach to Obtain High Yields of Biosimilars by Anti-apoptotic Cell Engineering: a Case Study to Increase the Production Yield of Anti-TNF Alpha Producing Recombinant CHO Cells

10. Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences

11. Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis

12. Treatment of severe psoriasis in children: recommendations of an Italian expert group

13. An Update on Treatment of Pediatric Chronic Non-infectious Uveitis

14. Clinical Signs, Pathophysiology and Management of Cutaneous Side Effects of Anti-Tumor Necrosis Factor Agents

15. Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective

16. Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis

17. Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study

18. Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis F

19. Adalimumab in refractory cystoid macular edema associated with birdshot chorioretinopathy

20. Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa

21. Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial

22. Adalimumab: A Review in Non-Infectious Non-Anterior Uveitis

23. Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry

24. Adalimumab-induced pulmonary sarcoidosis not progressing upon treatment with etanercept

25. Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece

26. Extrapolation and Interchangeability of Infliximab and Adalimumab in Inflammatory Bowel Disease

27. Systemic Treatment for Noninfectious Intraocular Inflammation

28. HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study

29. Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis


Questions?

Drop us a message.